HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heavy ion radiotherapy during pregnancy.

AbstractOBJECTIVE:
To provide a safe particle therapy treatment for a pregnant woman with skull-base cancer.
DESIGN:
Case report.
SETTING:
University clinic.
PATIENT(S):
A 27-year-old woman diagnosed for a skull-base chordoma and whose pregnancy was found during the course of radiotherapy with accelerated carbon ions.
INTERVENTION(S):
Therapy was continued as scheduled, and fetal dose produced by photons and neutrons was measured at each radiotherapy fraction using passive and active monitors.
MAIN OUTCOME MEASURE(S):
Radiation dose to the uterus. Health of the mother and the newborn.
RESULT(S):
Total dose to the uterus was <0.2 mSv. About 30% of this dose was caused by neutrons. Magnetic resonance imaging of the skull base showed no evidence of recurrent disease in the mother. The child was healthy with normal development.
CONCLUSION(S):
Heavy ion cancer therapy produces a very low dose in distal organs.
AuthorsMarc W Münter, Marc Wengenroth, Georg Fehrenbacher, Dieter Schardt, Anna Nikoghosyan, Marco Durante, Jürgen Debus
JournalFertility and sterility (Fertil Steril) Vol. 94 Issue 6 Pg. 2329.e5-7 (Nov 2010) ISSN: 1556-5653 [Electronic] United States
PMID20493478 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Carbon Radioisotopes
Topics
  • Adult
  • Carbon Radioisotopes (therapeutic use)
  • Chordoma (radiotherapy)
  • Female
  • Heavy Ion Radiotherapy
  • Humans
  • Infant, Newborn
  • Male
  • Pregnancy
  • Pregnancy Complications, Neoplastic (radiotherapy)
  • Radiation Protection
  • Radiometry
  • Skull Base Neoplasms (radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: